2'-deoxy-2'-methylenecytidine has been researched along with irinotecan in 1 studies
Studies (2'-deoxy-2'-methylenecytidine) | Trials (2'-deoxy-2'-methylenecytidine) | Recent Studies (post-2010) (2'-deoxy-2'-methylenecytidine) | Studies (irinotecan) | Trials (irinotecan) | Recent Studies (post-2010) (irinotecan) |
---|---|---|---|---|---|
30 | 2 | 0 | 8,002 | 1,885 | 3,752 |
Protein | Taxonomy | 2'-deoxy-2'-methylenecytidine (IC50) | irinotecan (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 2.7 | |
Interstitial collagenase | Homo sapiens (human) | 6.06 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.556 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.171 | |
Acetylcholinesterase | Homo sapiens (human) | 1.827 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.9 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 4.7667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Friberg, LE; Henningsson, A; Karlsson, MO; Maas, H; Nguyen, L | 1 |
1 other study(ies) available for 2'-deoxy-2'-methylenecytidine and irinotecan
Article | Year |
---|---|
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs.
Topics: Antineoplastic Agents; Bone Marrow; Camptothecin; Deoxycytidine; Docetaxel; Etoposide; Humans; Irinotecan; Leukocytes; Models, Biological; Neutrophils; Paclitaxel; Taxoids; Vinblastine | 2002 |